GeneDx Holdings Long-term Debt / Capital 2020-2025 | WGS
GeneDx Holdings long-term debt / capital from 2020 to 2025. Long-term debt / capital can be defined as a measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.066B | $0.305B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.181B | 25.92 |
| Elevance Health (ELV) | United States | $85.871B | 11.08 |
| CVS Health (CVS) | United States | $80.417B | 10.00 |
| Cencora (COR) | United States | $56.019B | 19.49 |
| Natera (NTRA) | United States | $22.833B | 0.00 |
| DiDi Global (DIDIY) | China | $22.168B | 33.64 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| Solventum (SOLV) | United States | $13.000B | 13.76 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.955B | 0.00 |
| CochLear (CHEOY) | Australia | $11.511B | 0.00 |
| ICON (ICLR) | Ireland | $11.274B | 10.48 |
| Revvity (RVTY) | United States | $10.891B | 18.74 |
| Doximity (DOCS) | United States | $10.250B | 47.45 |
| Viatris (VTRS) | United States | $10.082B | 3.46 |
| HealthEquity (HQY) | United States | $9.777B | 42.83 |
| Avantor (AVTR) | United States | $9.070B | 13.18 |
| Medpace Holdings (MEDP) | United States | $8.989B | 23.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.365B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.034B | 13.78 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| BrightSpring Health Services (BTSG) | United States | $4.109B | 38.03 |
| Bausch + Lomb (BLCO) | Canada | $4.068B | 23.98 |
| Sotera Health (SHC) | United States | $3.508B | 19.93 |
| Alignment Healthcare (ALHC) | United States | $3.031B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.955B | 38.43 |
| Concentras Parent (CON) | United States | $2.766B | 15.98 |
| Organon (OGN) | United States | $2.477B | 2.63 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| Premier (PINC) | United States | $1.908B | 14.48 |
| Progyny (PGNY) | United States | $1.826B | 40.19 |
| PACS (PACS) | United States | $1.550B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.432B | 28.64 |
| Teladoc Health (TDOC) | United States | $1.249B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.194B | 9.09 |
| Establishment Labs Holdings (ESTA) | $1.075B | 0.00 | |
| CareDx (CDNA) | United States | $1.075B | 16.78 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.907B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.768B | 7.19 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.753B | 11.41 |
| Embecta (EMBC) | United States | $0.608B | 4.09 |
| LifeMD (LFMD) | United States | $0.559B | 0.00 |
| Enhabit (EHAB) | United States | $0.538B | 44.25 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| SBC Medicals (SBC) | United States | $0.502B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.486B | 10.95 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.423B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.00 |
| KindlyMD (NAKA) | United States | $0.103B | 0.00 |
| So-Young (SY) | China | $0.097B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.073B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.046B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |